Autogenomics Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 109

Employees

  • Latest Deal Type
  • M&A

Autogenomics General Information

Description

Developer of an automated molecular testing technology intended to simplify the complex test processes inherent in genetic analysis. The company's automated molecular testing technology offers high-performance genetic marker detection with varying options in automation and throughput, allowing labs to analyze multiple genetic markers at once in a more efficient and automated way.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 1600 Faraday Avenue
  • Carlsbad, CA 92008
  • United States
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Parent Company
Vertical(s)
Corporate Office
  • 1600 Faraday Avenue
  • Carlsbad, CA 92008
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Autogenomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 23-Apr-2019 Completed Generating Revenue
8. IPO 24-Jul-2015 Cancelled Generating Revenue
7. Later Stage VC 11-Jan-2013 Completed Generating Revenue
6. Later Stage VC (Series E) Completed
5. Later Stage VC (Series D) 07-Jul-2010 Completed Generating Revenue
4. Later Stage VC 08-Jun-2010 Completed Generating Revenue
3. Later Stage VC (Series C) 29-Mar-2007 Completed Generating Revenue
2. Later Stage VC (Series B) 20-Jul-2005 $12.3M $17.3M Completed Generating Revenue
1. Early Stage VC (Series A) 20-Jun-2003 $4.99M $4.99M Completed Generating Revenue
To view Autogenomics’s complete valuation and funding history, request access »

Autogenomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series NC
Series E
Series D
Series C
Series B 4,515,858 $0.010000 $0.17 $2.75 $2.75 1x $7.55 12.66%
Series A 1,589,600 $0.010000 $0.19 $3.16 $3.16 1x $4.79 8.11%
To view Autogenomics’s complete cap table history, request access »

Autogenomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an automated molecular testing technology intended to simplify the complex test processes inherent in genet
Biotechnology
Carlsbad, CA
109 As of 2014

South San Francisco, CA
 

Oklahoma City, OK
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Autogenomics Competitors (33)

One of Autogenomics’s 33 competitors is Superfluid DX, a Venture Capital-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Superfluid DX Venture Capital-Backed South San Francisco, CA
Progentec Venture Capital-Backed Oklahoma City, OK
Complete Genomics Formerly VC-backed San Jose, CA
Advanced Cell Diagnostics Formerly VC-backed Minneapolis, MN
Cepheid Formerly VC-backed Sunnyvale, CA
You’re viewing 5 of 33 competitors. Get the full list »

Autogenomics Patents

Autogenomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025255177-A1 Glucagon-like peptide-1 receptor related biomarkers and uses thereof Pending 03-Jun-2024
EP-4022066-A1 Methods and systems for evaluation of risk of substance use disorders Pending 27-Aug-2019
EP-4022066-A4 Methods and systems for evaluation of risk of substance use disorders Pending 27-Aug-2019
US-10998105-B2 Methods and systems for evaluation of risk of substance use disorders Active 27-Aug-2019
US-20210065909-A1 Methods and systems for evaluation of risk of substance use disorders Active 27-Aug-2019 G16H20/10
To view Autogenomics’s complete patent history, request access »

Autogenomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Autogenomics Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bantam Group Angel Group Minority
Catalina Ventures Venture Capital Minority
MemorialCare Innovation Fund Corporate Venture Capital Minority
Angel (individual) Minority
To view Autogenomics’s complete investors history, request access »

Autogenomics FAQs

  • When was Autogenomics founded?

    Autogenomics was founded in 1999.

  • Where is Autogenomics headquartered?

    Autogenomics is headquartered in Carlsbad, CA.

  • What is the size of Autogenomics?

    Autogenomics has 109 total employees.

  • What industry is Autogenomics in?

    Autogenomics’s primary industry is Biotechnology.

  • Is Autogenomics a private or public company?

    Autogenomics is a Private company.

  • What is Autogenomics’s current revenue?

    The current revenue for Autogenomics is .

  • How much funding has Autogenomics raised over time?

    Autogenomics has raised $82.9M.

  • Who are Autogenomics’s investors?

    Bantam Group, Catalina Ventures, MemorialCare Innovation Fund, and have invested in Autogenomics.

  • Who are Autogenomics’s competitors?

    Superfluid DX, Progentec, Complete Genomics, Advanced Cell Diagnostics, and Cepheid are some of the 33 competitors of Autogenomics.

  • When was Autogenomics acquired?

    Autogenomics was acquired on 23-Apr-2019.

  • Who acquired Autogenomics?

    Autogenomics was acquired by SOLVD Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process